In vitro anti-mycobacterial activities of various 2′-deoxyuridine, 2′-arabinouridine and 2′-arabinofluoro-2′-deoxyuridine analogues: Synthesis and biological studies

Medicinal Chemistry

Volumn 2, Issue 3, 2006, Pages 287-293

  Srivastav, Naveen C ^a   Manning, Tracey ^a   Kunimoto, Dennis Y ^a   Kumar, Rakesh ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Anti microbial agent; Heterocycle; Tuberculosis

Indexed keywords

1 DELTA DEXTRO ARABINOFURANOSYL 5 FLUOROURACIL; 1 DELTA DEXTRO ARABINOFURANOSYL 5 IODOURACIL; 1 DELTA DEXTRO ARABINOFURANOSYLCYTOSINE; 1 DELTA DEXTRO ARABINOFURANOSYLTHYMINE; 1 DELTA DEXTRO ARABINOFURANOSYLURACIL; 2' ARABINOFLUORO 2' DEOXYURIDINE DERIVATIVE; 2' ARABINOURIDINE DERIVATIVE; 3 AZIDO 2,3 DIHYDRO 5 (2',3',5' TRI O ACETYL BETA DEXTRO ARABINOFURONOSYL)FURANO[2,3 D]PYRIMIDIN 6(5H) ONE; 5 (1 AZIDO 2 BROMOETHYL) 2' DEOXYURIDINE; 5 (1 AZIDO 2 BROMOETHYL) 2',3',5' TRI O ACETYLARABINOURIDINE; 5 (1 AZIDO 2 BROMOETHYL) 3',5' DI O TERT BUTYLDIMETHYLSILYLARABINOURIDINE; 5 (1 AZIDO 2 HALOETHYL)ARABINOURIDINE DERIVATIVE; 5 (1 AZIDO 2 IODOETHYL) 2' DEOXYURIDINE; 5 (1 AZIDO 2,2 DIBROMOETHYL) 2' DEOXYURIDINE; 5 (1 AZIDO 2,2 DICHLOROETHYL) 2' DEOXYURIDINE; 5 (1 AZIDOVINYL) 2' DEOXYURIDINE; 5 (1 AZIDOVINYL) 3',5' DI O TERT BUTYLDIMETHYLSILYLARABINOURIDINE; 5 (1 AZIDOVINYL)ARABINOURIDINE; 5 (1 CYANAMIDO 2 BROMOETHYL)ARABINOURIDINE; 5 (1 CYANAMIDO 2 IODOETHYL)ARABINOURIDINE; 5 (2 CHLOROVINYL)ARABINOURIDINE; 5 (2',3',5' TRI O ACETYL DELTA DEXTRO ARABINOFURONOSYL)FURANO[2,3 D]PYRIMIDIN 6(5H) ONE; 5 ETHYL 2' ARABINOFLUORO 2' DEOXYURIDINE; 5 IODO 2' ARABINOFLUORO 2' DEOXYURIDINE; 5 IODOARABINOURIDINE; 5 VINYL 3',5' DI O TERT BUTYLDIMETHYLSILYLARABINOURIDINE; ANTIMYCOBACTERIAL AGENT; CYTIDINE DERIVATIVE; DEOXYURIDINE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; DEOXYURIDINE; MAGNETIC RESONANCE SPECTROSCOPY; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM; SPECIES SPECIFICITY;

EID: 33746120251     PISSN: 15734064     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340606776930745     Document Type: Article

References (27)

1. Pilheu, JA. Int. J. Tuberc Lung Dis., 1998, 2, 696-703.
2. Raviglione, M.C.; Snider, DE.; Kochi, A. J. Am. Med. Assoc., 1995, 273, 220-226.
3. Willcox, P.A. Curr. Opinion Pulm. Med, 2000, 6, 198-202.
4. b) Méndez, A.P.; Raviglione, M.C.; Laszlo, A.; Binkin, N.; Rieder, H.L.; Bustreo, F.; Cohn, D.L.; Weezenbeek, C.S.B. L-van.; Kim, S. J.; Chaulet, P.; Nunn, P. N Engl. J. Med, 1998, 338, 1641-1649.
5. Pozniak, A.J. HIV Ther., 2002, 7, 13-16.
6. Colditz, GA; Brewer, T.F.; Berkey, C.S.; Wilson, M.E.; Burdick, E.; Fineberg, H.V.; Mosteller, F. JAMA, 1994, 271, 698-702.
7. a) Koehler, C.S.W. Modern Drug Disc., 2002, 47-49.
8. b) Guerrero, A. Lancet, 1997, 350, 1738-1742.
9. Inderlied, C.B.; Kemper, C.A.; Bermudez, L.E. Clin. Microbiol. Rev., 1993, 6, 266-310.
10. Falkinham, J. O. III. Clin. Microbiol. Rev., 1996, 9, 177-215.
11. Dautzenberg, B. Res. Microbiol., 1994, 145, 197-206.
12. Ellner, J.J.; Goldberger, M. J.; Parenti, D.M. J. Infect Dis., 1991, 163, 1326-1335.
13. Johar, M.; Manning T.; Kunimoto, D.Y.; Kumar, R. Bioorg. Med. Chem, 2005, 13, 6663-6671.
14. Hansch, C.; Leo, A.; Unger, S.H.; Kim, K. H.; Nikaitani, D.; Lien, E. J. J. Med. Chem., 1973, 16, 1207-1216.
15. Kumar, R.; Wiebe, L. I.; Knaus, E. E. J. Med. Chem., 1993, 36, 2470-2474.
16. Walker, R.T.; Balzarini, J.; Coe, P.L.; De Clereq, E.; Harnden, M.R.; Jones, A.S.; Noble, S.A.; Rahim S.G. Nucleic Acids Res. Symp. Ser., 1982, No. 11, 215.
17. Goodchild, J.; Wadsworth, H.J.; Sim, I.S. Nucleosides Nucleotides, 1986, 5, 571.
18. Machida, S.; Watanabe, Y.; Kano, F.; Sakata, S.; Kumagai, M.; Yamaguch, T. Biochem. Pharmacol., 1995, 49, 763-766.
19. Kumar, R.; Wiebe L.I.; Knaus E.E. Can J. Chem., 1996, 74, 1609-1615.
20. Kumar, R.; Wang L.; Wiebe L.I.; Knaus E.E. Pharm. Sci. Comm., 1994, 4, 161-170.
21. Kumar, R.; Wiebe L.I.; Knaus E.E. J. Heterocyclic. Chem., 1997, 34, 1369-1370.
22. Kumar, R.; Rai D.; Sharma, S.K; Saffran R.; Blush, R.; Tyrrell, D.L.J.J. Med. Chem., 2001, 44, 3531-3538.
23. Kumar, R.; Wiebe, L. I.; Knaus, E. E. Can. J. Chem., 1994, 72, 2005-2010.
24. Ashida, N.; Sakata S.; Kano, F.; Nishitani, M.; Watanabe, Y.; Machida, H. Antiviral Res., 1994, 25, 179-184.
25. Franzblau, S.G.; Witzig, R.S.; McLaughlin, J.C.; Torres, P.; Madico, G.; Hernandez, A.; Degnan, M.T.; Cook, M.B.; Quenzer, V.K.; Ferguson, R.M.; Gilman R.H. J. Clin. Microbiol., 1998, 36, 362-366.
26. b) Collins, L.; Franzblau, S.G. Antimicrob. Agents. Chemother., 1997, 41, 1004-1009.
27. Ashida, N.; Watanabe, Y.; Shinji, M.; Kano, F.; Sakata, S.; Yamaguchi, T.; Sizitani, T.; Machida, H. Antiviral Res., 1997, 35, 167-175.